128 related articles for article (PubMed ID: 9839883)
21. MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.
Pu R; Omori M; Okada S; Rine SL; Lewis BA; Lipton E; Yamamoto JK
Cell Immunol; 1999 Nov; 198(1):30-43. PubMed ID: 10612649
[TBL] [Abstract][Full Text] [Related]
22. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256
[TBL] [Abstract][Full Text] [Related]
23. Quantification of feline immunodeficiency virus (FIV) proviral DNA in peripheral blood mononuclear cells of cats infected with Japanese strains of FIV.
Inoshima Y; Tomonaga K; Ikeda Y; Miyazawa T; Mikami T
J Vet Med Sci; 1995 Jun; 57(3):487-92. PubMed ID: 7548402
[TBL] [Abstract][Full Text] [Related]
24. Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus.
Rideout BA; Moore PF; Pedersen NC
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):71-81. PubMed ID: 1363010
[TBL] [Abstract][Full Text] [Related]
25. The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats.
Arai M; Darman J; Lewis A; Yamamoto JK
Vet Immunol Immunopathol; 2000 Nov; 77(1-2):71-92. PubMed ID: 11068067
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cofactor effect of feline syncytium-forming virus on feline immunodeficiency virus infection.
Zenger E; Brown WC; Song W; Wolf AM; Pedersen NC; Longnecker M; Li J; Collisson EW
Am J Vet Res; 1993 May; 54(5):713-8. PubMed ID: 8391229
[TBL] [Abstract][Full Text] [Related]
27. Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase.
Eckstrand CD; Hillman C; Smith AL; Sparger EE; Murphy BG
PLoS One; 2016; 11(1):e0146285. PubMed ID: 26741651
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of in vivo and in vitro interactions of feline immunodeficiency virus and feline leukemia virus.
Beebe AM; Faith TG; Sparger EE; Torten M; Pedersen NC; Dandekar S
AIDS; 1994 Jul; 8(7):873-8. PubMed ID: 7946095
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
Levy JK; Crawford PC; Kusuhara H; Motokawa K; Gemma T; Watanabe R; Arai S; Bienzle D; Hohdatsu T
J Vet Intern Med; 2008; 22(2):330-4. PubMed ID: 18371028
[TBL] [Abstract][Full Text] [Related]
30. Distribution of immune cells in the female reproductive tract in uninfected and FIV infected cats.
Butterworth JL; English RV; Jordan HL; Tompkins MB
Vet Immunol Immunopathol; 2001 Nov; 83(1-2):37-51. PubMed ID: 11604160
[TBL] [Abstract][Full Text] [Related]
31. Selective thymocyte depletion and immunoglobulin coating in the thymus of cats infected with feline immunodeficiency virus.
Orandle MS; Papadi GP; Bubenik LJ; Dailey CI; Johnson CM
AIDS Res Hum Retroviruses; 1997 May; 13(7):611-20. PubMed ID: 9135879
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of hematological abnormalities and detection of infected bone marrow cells in asymptomatic cats with feline immunodeficiency virus infection.
Fujino Y; Horiuchi H; Mizukoshi F; Baba K; Goto-Koshino Y; Ohno K; Tsujimoto H
Vet Microbiol; 2009 May; 136(3-4):217-25. PubMed ID: 19110384
[TBL] [Abstract][Full Text] [Related]
33. Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.
Boretti FS; Leutenegger CM; Mislin C; Hofmann-Lehmann R; König S; Schroff M; Junghans C; Fehr D; Huettner SW; Habel A; Flynn JN; Aubert A; Pedersen NC; Wittig B; Lutz H
AIDS; 2000 Aug; 14(12):1749-57. PubMed ID: 10985311
[TBL] [Abstract][Full Text] [Related]
34. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
35. CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro.
Hohdatsu T; Sasagawa T; Yamazaki A; Motokawa K; Kusuhara H; Kaneshima T; Koyama H
Arch Virol; 2002 Aug; 147(8):1517-29. PubMed ID: 12181672
[TBL] [Abstract][Full Text] [Related]
36. Programmed cell death (apoptosis) as a mechanism of cell death in peripheral blood mononuclear cells from cats infected with feline immunodeficiency virus (FIV).
Bishop SA; Gruffydd-Jones TJ; Harbour DA; Stokes CR
Clin Exp Immunol; 1993 Jul; 93(1):65-71. PubMed ID: 8391941
[TBL] [Abstract][Full Text] [Related]
37. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
38. Ability of CD8(+) T cell anti-feline immunodeficiency virus activity correlated with peripheral CD4(+) T cell counts and plasma viremia.
Hohdatsu T; Yamazaki A; Yamada M; Kusuhara H; Kaneshima T; Koyama H
Microbiol Immunol; 2003; 47(10):765-73. PubMed ID: 14605443
[TBL] [Abstract][Full Text] [Related]
39. Enhanced expression of novel CD57+CD8+ LAK cells from cats infected with feline immunodeficiency virus.
Zhao Y; Gebhard D; English R; Sellon R; Tompkins M; Tompkins W
J Leukoc Biol; 1995 Oct; 58(4):423-31. PubMed ID: 7561518
[TBL] [Abstract][Full Text] [Related]
40. Transmission of feline immunodeficiency virus from infected queens to kittens.
Wasmoen T; Armiger-Luhman S; Egan C; Hall V; Chu HJ; Chavez L; Acree W
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):83-93. PubMed ID: 1337404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
